Inventor · disambiguated record
Renato Skerlj
Also filed as: SKERLJ RENATO · SKERLJ RENATO T · SKERLJ RENATO TONY
71 granted patents·38 pending applications·1,379 citations·filing 1992–2024
99Inventor score
Files withGENZYME CORP26ANORMED INC18BIAL R&D INVEST S A15LYSOSOMAL THERAPEUTICS INC15X4 PHARMACEUTICALS INC9
Top patents by PatentIndex Score
109 records- 0196US11091492B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 17, 2021·5 cites·38 claims
- 0296US10786508B2Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2018·Granted Sep 29, 2020·10 cites·30 claims
- 0396US10751341B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·12 cites·35 claims
- 0496US9732089B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Aug 15, 2017·20 cites·28 claims
- 0596US7863293B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2007·Granted Jan 4, 2011·24 cites·18 claims
- 0696US5583131AAromatic-linked polyamine macrocyclic compounds with anti-HIV activityJOHNSON MATTHEY PLC·Filed 1992·Granted Dec 10, 1996·172 cites·35 claims
- 0795US11932645B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Mar 19, 2024·2 cites·20 claims
- 0895US10759796B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2017·Granted Sep 1, 2020·6 cites·26 claims
- 0995US9920061B2Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·16 cites·30 claims
- 1095US9868742B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Jan 16, 2018·17 cites·30 claims
- 1195US9840510B1Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·16 cites·30 claims
- 1295US7291631B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2004·Granted Nov 6, 2007·50 cites·25 claims
- 1394US11351173B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Jun 7, 2022·3 cites·19 claims
- 1494US10570135B2Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Granted Feb 25, 2020·13 cites·18 claims
- 1594US7709486B2CXCR4 antagonistsGENZYME CORP·Filed 2008·Granted May 4, 2010·20 cites·6 claims
- 1694US7452994B2Synthesis of enantiomerically pure amino-substituted fused bicyclic ringsANORMED INC·Filed 2006·Granted Nov 18, 2008·18 cites·11 claims
- 1794US7354934B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2005·Granted Apr 8, 2008·34 cites·10 claims
- 1894US6864265B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Mar 8, 2005·42 cites·6 claims
- 1994US6825351B2Synthesis of enantiomerically pure amino-substituted fused bicyclic ringsANORMED INC·Filed 2002·Granted Nov 30, 2004·34 cites·7 claims
- 2094US6750348B1Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2000·Granted Jun 15, 2004·61 cites·30 claims
- 2193US10934298B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2019·Granted Mar 2, 2021·10 cites·30 claims
- 2293US7091217B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Aug 15, 2006·31 cites·12 claims
- 2393US6835731B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Dec 28, 2004·53 cites·10 claims
- 2493US6734191B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted May 11, 2004·35 cites·15 claims
- 2592US11400095B2Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 2, 2022·2 cites·16 claims
- 2692US11306088B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2020·Granted Apr 19, 2022·2 cites·21 claims
- 2792US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 2892US5817807AAntiviral compoundsANORMED INC·Filed 1996·Granted Oct 6, 1998·145 cites·5 claims
- 2992US5698546ACyclic polyaminesJOHNSON MATTHEY PUBLIC LIMTED·Filed 1995·Granted Dec 16, 1997·157 cites·17 claims
- 3091US10787454B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL BIOTECH INVEST INC·Filed 2017·Granted Sep 29, 2020·10 cites·24 claims
- 3191US7332605B2Process for the synthesis of CXCR4 antagonistANORMED INC·Filed 2005·Granted Feb 19, 2008·26 cites·38 claims
- 3290US11453675B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Sep 27, 2022·2 cites·18 claims
- 3390US11168087B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2017·Granted Nov 9, 2021·4 cites·18 claims
- 3490US7723525B2Chemokine-binding heterocyclic compound salts, and methods of use thereofGENZYME CORP·Filed 2005·Granted May 25, 2010·20 cites·10 claims
- 3590US7354932B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2003·Granted Apr 8, 2008·27 cites·21 claims
- 3689US11878979B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Jan 23, 2024·1 cites·22 claims
- 3789US6756391B2Antiviral compoundsANORMED INC·Filed 2002·Granted Jun 29, 2004·23 cites·7 claims
- 3888US7501518B2Methods of making 2,6-diaryl piperidine derivativesGENZYME CORP·Filed 2004·Granted Mar 10, 2009·19 cites·6 claims
- 3988US7414065B2Methods to modulate conditions mediated by the CXCR4 receptorGENZYME CORP·Filed 2004·Granted Aug 19, 2008·20 cites·8 claims
- 4088US7160872B2Methods to treat conditions mediated by chemokine receptorsANORMED INC·Filed 2004·Granted Jan 9, 2007·20 cites·12 claims
- 4188US7135570B2Synthesis of enantiomerically pure amino-substituted fused bicyclic ringsANORMED INC·Filed 2004·Granted Nov 14, 2006·18 cites·10 claims
- 4288US6506770B1Antiviral compoundsANORMED INC·Filed 1998·Granted Jan 14, 2003·53 cites·7 claims
- 4387US9493510B2Peptidomimetic compoundsNOLIVA THERAPEUTICS LLC·Filed 2014·Granted Nov 15, 2016·7 cites·11 claims
- 4486US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 4586US11192892B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Dec 7, 2021·4 cites·18 claims
- 4686US2025066364A1Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL R&D INVEST S A·Filed 2024·Application pending·0 cites
- 4784US7550484B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2004·Granted Jun 23, 2009·19 cites·11 claims
- 4884US6667320B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2000·Granted Dec 23, 2003·17 cites·19 claims
- 4983US11124516B2Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Sep 21, 2021·4 cites·16 claims
- 5083US2024150350A1Cxcr4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 109 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →